Evidence map›Paper›PMID 33494755›Full record

ReviewJournal of neuroengineering and rehabilitation2021

A review of movement disorders in chemotherapy-induced neurotoxicity.

Allison B Wang, Stephen N Housley, Ann Marie Flores, Sheetal M Kircher, Eric J Perreault, Timothy C Cope

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Journal of neuroengineering and rehabilitation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06610617 (Neuromodulation of Central Sensory Integration to Improve Postural Control), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06610617 nacompletednot on this mapstarted 2024, after this paper: background citation

Neuromodulation of Central Sensory Integration to Improve Postural Control: A Pilot Study in Older Women With Breast Cancer

TypeinterventionalSponsorUniversity of PittsburghRan2024 to 2025Enrolled48ConditionsSurvivorship, Quality of Life, Cognitive Deficits, MildArmstranscranial direct current stimulation (tDCS), Sham tDCS
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Excitatory and Inhibitory Descending Commissural Interneurons Differentially Integrate Supraspinal and Segmental Sensory Signals.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Mechanisms of cancer pain.Frontiers in pain research (Lausanne, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Allison B WangDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, USA. bwang15@u.northwestern.edu.ORCID 0000-0002-0660-9138
Stephen N HousleySchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.
Ann Marie FloresDepartment of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, IL, USA.
Sheetal M KircherCancer Survivorship Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.
Eric J PerreaultDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, USA.
Timothy C CopeSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.
Northwestern University · USGeorgia Institute of Technology · US

Funding

Multiscale models of proprioceptive encoding to reveal mechanisms of impaired sensorimotor controlR01HD090642 · NICHD · EMORY UNIVERSITY · PI COPE, TIMOTHY C, SAWICKI, GREGORY STEPHEN · 2016 to 2025
$4.9M
Interdisciplinary Graduate Education in Movement and Rehabilitation Sciences-RenewalT32EB009406 · NIBIB · NORTHWESTERN UNIVERSITY AT CHICAGO · PI JULIUS P DEWALD, JUN YAO · 2009 to 2026
$2.2M
Novel Path to Chronic Sensorimotor Dysfunction and Treatment for ChemotherapyR01CA221363 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI COPE, TIMOTHY C · 2018 to 2022
$1.5M
Effects of oxaliplatin-based chemotherapy on proprioception in cancer survivorsF31NS118832 · NINDS · NORTHWESTERN UNIVERSITY · PI WANG, ALLISON BINGQING · 2020 to 2021
$83k
NCI NIH HHS R01 CA221363NCI NIH HHS R01-CA221363NIBIB NIH HHS T32 EB009406NICHD NIH HHS R01 HD090642NIH HHS F31-NS118832NIH HHS T32-EB009406NINDS NIH HHS F31 NS118832
6 · The paper itself

Abstract

Chemotherapy agents used in the standard treatments for many types of cancer are neurotoxic and can lead to lasting sensory and motor symptoms that compromise day-to-day movement functions in cancer survivors. To date, the details of movement disorders associated with chemotherapy are known largely through self-reported symptoms and functional limitations. There are few quantitative studies of specific movement deficits, limiting our understanding of dysfunction, as well as effective assessments and interventions. The aim of this narrative review is to consolidate the current understanding of sensorimotor disabilities based on quantitative measures in cancer survivors who received chemotherapy. We performed literature searches on PubMed and found 32 relevant movement studies. We categorized these studies into three themes based on the movement deficits investigated: (1) balance and postural control; (2) gait function; (3) upper limb function. This literature suggests that cancer survivors have increased postural sway, more conservative gait patterns, and suboptimal hand function compared to healthy individuals. More studies are needed that use objective measures of sensorimotor function to better characterize movement disabilities and investigate the underlying causes, as required for developing targeted assessments and interventions. By updating our understanding of movement impairments in this population, we identify significant gaps in knowledge that will help guide the direction of future research.

Indexed as

Neurotoxicity SyndromesAntineoplastic AgentsHumansMovement DisordersNeoplasmsPeripheral Nervous System DiseasesAntineoplastic AgentsCancerChemotherapyCIPNNeuropathySensorimotor dysfunction

Identifiers

PMID33494755
PMCPMC7836454
OpenAlexW3123603299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.